BioStem Life Sciences announces expansion; contract manufacturing capabilities, and research and development laboratory

This article was originally published here

Situated in the Company’s 6,100 sq. Ft., state-of-the-art, FDA registered, cGMP facility, this new lab will support the research and development pipeline for the Company’s growing Contract Development

The post BioStem Life Sciences announces expansion; contract manufacturing capabilities, and research and development laboratory appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply